| Back |
|
| For an immediate cooling effect |
| Product Name: |
| Tablet / Suspension (100 ml / 200 ml) |
| Sucralfate 1g / 1g per 10ml |
| Cools the excessive acid thrust |
| Sucralfate |
| * FDA approved for use in patients with active duodenal ulcers |
| ** Prevents acid, pepsin and bile from coming in contact with ulcer base |
| *** Effective drug for the prophylaxis and management of stress-induced gastrointestinal bleeding in severely ill patients, and reduces the risk of late onset pneumonia compared with an H2 antagonist |
| **** Treatment with sucralfate significantly inhibited the mucosal damage induced by duodenal perfusion with acid |
| Safe in Pregnancy |
| * Not systemically absorbed and has few adverse effects; therefore, commonly used during pregnancy. |
|
|
| DUODENAL & GASTRIC ULCER
|
| CHRONIC GASTRITIS
|
| REFLUX OESOPHAGITIS
|
| BILE REFLUX
|
|
Medical Jr.
| 1. Annals of Internal Medicine, vol. 97, no.2, Aug 1982
|
| 2. Drug safety 1998 oct; 19(4): 325-337
|
| 3. Aliment Pharmacol Ther 1999; 13: 1363-1371
|
|
| |
|
 |